A detailed history of Wall Street Access Asset Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wall Street Access Asset Management, LLC holds 7,783 shares of BMY stock, worth $320,036. This represents 0.18% of its overall portfolio holdings.

Number of Shares
7,783
Previous 6,833 13.9%
Holding current value
$320,036
Previous $350,000 20.57%
% of portfolio
0.18%
Previous 0.17%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$47.98 - $54.4 $45,581 - $51,680
950 Added 13.9%
7,783 $422,000
Q4 2023

Apr 25, 2024

SELL
$48.48 - $57.85 $72,720 - $86,775
-1,500 Reduced 18.0%
6,833 $350,000
Q4 2023

Feb 13, 2024

SELL
$48.48 - $57.85 $72,720 - $86,775
-1,500 Reduced 18.0%
6,833 $350,000
Q3 2023

Apr 25, 2024

SELL
$57.89 - $64.73 $28,945 - $32,365
-500 Reduced 5.66%
8,333 $483,000
Q3 2023

Nov 06, 2023

SELL
$57.89 - $64.73 $28,945 - $32,365
-500 Reduced 5.66%
8,333 $483,000
Q2 2023

Apr 25, 2024

BUY
$63.71 - $70.74 $50,968 - $56,591
800 Added 9.96%
8,833 $564,000
Q2 2023

Oct 20, 2023

BUY
$63.71 - $70.74 $562,750 - $624,846
8,833 New
8,833 $564,000
Q1 2023

Apr 25, 2024

BUY
$65.71 - $74.53 $210,271 - $238,496
3,200 Added 66.21%
8,033 $556,000
Q1 2023

May 11, 2023

BUY
$65.71 - $74.53 $210,271 - $238,496
3,200 Added 66.21%
8,033 $556,000
Q4 2022

Apr 25, 2024

SELL
$68.48 - $81.09 $136,960 - $162,180
-2,000 Reduced 29.27%
4,833 $347,000
Q4 2021

Feb 15, 2022

BUY
$53.63 - $62.52 $259,193 - $302,159
4,833 New
4,833 $301,000
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $305,198 - $357,500
-5,158 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$61.91 - $67.42 $92,865 - $101,130
-1,500 Reduced 22.53%
5,158 $344,000
Q1 2021

May 13, 2021

BUY
$59.34 - $66.74 $89,010 - $100,109
1,500 Added 29.08%
6,658 $420,000
Q4 2020

Feb 12, 2021

BUY
$57.74 - $65.43 $297,822 - $337,487
5,158 New
5,158 $319,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $87.4B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Wall Street Access Asset Management, LLC Portfolio

Follow Wall Street Access Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wall Street Access Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wall Street Access Asset Management, LLC with notifications on news.